Viewing Study NCT00693992


Ignite Creation Date: 2025-12-24 @ 3:27 PM
Ignite Modification Date: 2026-01-03 @ 6:42 AM
Study NCT ID: NCT00693992
Status: COMPLETED
Last Update Posted: 2019-06-11
First Post: 2008-06-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage IIIB Lung Non-Small Cell Cancer AJCC v7 View
None Stage IV Non-Small Cell Lung Cancer AJCC v7 View
Keywords: